Review



ivd labeled elisas  (Uman Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Uman Diagnostics ivd labeled elisas
    Ivd Labeled Elisas, supplied by Uman Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivd+labeled+elisas/elisas+ivd+labeled/pmc13127386-221-2-17
    Average 86 stars, based on 1 article reviews
    ivd labeled elisas - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosis.
    Article Snippet: Commercially available IVD-labeled ELISAs were used according to the manufacturer’s protocol for measuring Neurofilament light (10–7001 CE, Umandiagnostics AB, Umea, Sweden). iScience 29, 115636, May 15, 2026 e2

    Article Title: Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosis
    Article Snippet: Commercially available IVD-labeled ELISAs were used according to the manufacturer's protocol for measuring Neurofilament light (10–7001 CE, Umandiagnostics AB, Umea, Sweden).



    Similar Products

    ivd labeled elisas  (Uman Diagnostics)
    86
    Uman Diagnostics ivd labeled elisas
    Ivd Labeled Elisas, supplied by Uman Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivd+labeled+elisas/elisas+ivd+labeled/pmc13127386-221-2-17
    Average 86 stars, based on 1 article reviews
    ivd labeled elisas - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    ivd-labeled elisas equation 6561–9601  (EUROIMMUN)
    90
    EUROIMMUN ivd-labeled elisas equation 6561–9601
    Ivd Labeled Elisas Equation 6561–9601, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivd+labeled+elisas/ivd+labeled+elisas+equation+6561+9601/pmc09804063-59-2-24
    Average 90 stars, based on 1 article reviews
    ivd-labeled elisas equation 6561–9601 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    ivd-labeled elisas 10–7001 ce  (Uman Diagnostics)
    90
    Uman Diagnostics ivd-labeled elisas 10–7001 ce
    Ivd Labeled Elisas 10–7001 Ce, supplied by Uman Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivd+labeled+elisas/ivd+labeled+elisas+10+7001+ce/pmc09804063-59-2-16
    Average 90 stars, based on 1 article reviews
    ivd-labeled elisas 10–7001 ce - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    sars-cov-2-igg ce-ivd labelled elisa kits  (EUROIMMUN)
    90
    EUROIMMUN sars-cov-2-igg ce-ivd labelled elisa kits
    Correlation of SARS-CoV-2 neutralization titres (FRNT90) to A: SARS-CoV-2 whole-virion IgG <t>ELISA;</t> B: S1 IgG ELISA; C: RBD IgG ELISA and D: N IgG ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
    Sars Cov 2 Igg Ce Ivd Labelled Elisa Kits, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivd+labeled+elisas/anti+sars+cov+2+elisa++igg+/pmc08079054-65-11-17
    Average 90 stars, based on 1 article reviews
    sars-cov-2-igg ce-ivd labelled elisa kits - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    sars-cov-2-igg ce-ivd labelled elisa kits  (Virotech Diagnostics GmbH)
    90
    Virotech Diagnostics GmbH sars-cov-2-igg ce-ivd labelled elisa kits
    Correlation of SARS-CoV-2 neutralization titres (FRNT90) to A: SARS-CoV-2 whole-virion IgG <t>ELISA;</t> B: S1 IgG ELISA; C: RBD IgG ELISA and D: N IgG ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
    Sars Cov 2 Igg Ce Ivd Labelled Elisa Kits, supplied by Virotech Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivd+labeled+elisas/sars+cov+2+elisa+igg/pmc08079054-65-11-19
    Average 90 stars, based on 1 article reviews
    sars-cov-2-igg ce-ivd labelled elisa kits - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    ce ivd-labelled elisas for hiv, hbsag, and hcv  (HUMAN Gesellschaft)
    90
    HUMAN Gesellschaft ce ivd-labelled elisas for hiv, hbsag, and hcv
    Correlation of SARS-CoV-2 neutralization titres (FRNT90) to A: SARS-CoV-2 whole-virion IgG <t>ELISA;</t> B: S1 IgG ELISA; C: RBD IgG ELISA and D: N IgG ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.
    Ce Ivd Labelled Elisas For Hiv, Hbsag, And Hcv, supplied by HUMAN Gesellschaft, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivd+labeled+elisas/ce+ivd+labelled+elisas+for+hiv++hbsag++and+hcv/10__1016_slash_s1473___3099_ascii40_18_ascii41_30343___8-18-45-46
    Average 90 stars, based on 1 article reviews
    ce ivd-labelled elisas for hiv, hbsag, and hcv - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Correlation of SARS-CoV-2 neutralization titres (FRNT90) to A: SARS-CoV-2 whole-virion IgG ELISA; B: S1 IgG ELISA; C: RBD IgG ELISA and D: N IgG ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Journal: Emerging Microbes & Infections

    Article Title: Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

    doi: 10.1080/22221751.2021.1913973

    Figure Lengend Snippet: Correlation of SARS-CoV-2 neutralization titres (FRNT90) to A: SARS-CoV-2 whole-virion IgG ELISA; B: S1 IgG ELISA; C: RBD IgG ELISA and D: N IgG ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Article Snippet: S1- and nucleocapsid specific IgG antibodies were detected with commercially available SARS-CoV-2-IgG CE-IVD labelled ELISA kits from Euroimmun and Virotech respectively.

    Techniques: Neutralization, Enzyme-linked Immunosorbent Assay, Binding Assay

    Correlation of SARS-CoV-2 neutralization titres (FRNT90) of A: mild COVID-19 patients and B: severe COVID-19 patients to SARS-CoV-2 whole-virion IgG ELISA, S1 IgG ELISA, RBD IgG ELISA and N IgG ELISA Abbreviations: COVID-19: corona virus induced disease 19; FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Journal: Emerging Microbes & Infections

    Article Title: Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

    doi: 10.1080/22221751.2021.1913973

    Figure Lengend Snippet: Correlation of SARS-CoV-2 neutralization titres (FRNT90) of A: mild COVID-19 patients and B: severe COVID-19 patients to SARS-CoV-2 whole-virion IgG ELISA, S1 IgG ELISA, RBD IgG ELISA and N IgG ELISA Abbreviations: COVID-19: corona virus induced disease 19; FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Article Snippet: S1- and nucleocapsid specific IgG antibodies were detected with commercially available SARS-CoV-2-IgG CE-IVD labelled ELISA kits from Euroimmun and Virotech respectively.

    Techniques: Neutralization, Enzyme-linked Immunosorbent Assay, Virus, Binding Assay

    Correlation of SARS-CoV-2 neutralization titres (FRNT90) to RBD IgGAM ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; **** = p < 0.0001.

    Journal: Emerging Microbes & Infections

    Article Title: Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

    doi: 10.1080/22221751.2021.1913973

    Figure Lengend Snippet: Correlation of SARS-CoV-2 neutralization titres (FRNT90) to RBD IgGAM ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; **** = p < 0.0001.

    Article Snippet: S1- and nucleocapsid specific IgG antibodies were detected with commercially available SARS-CoV-2-IgG CE-IVD labelled ELISA kits from Euroimmun and Virotech respectively.

    Techniques: Neutralization, Enzyme-linked Immunosorbent Assay, Binding Assay

    Correlation of SARS-CoV-2 neutralization titres (FRNT90) to A: SARS-CoV-2 whole-virion IgG ELISA; B: S1 IgG ELISA; C: RBD IgG ELISA and D: N IgG ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Journal: Emerging Microbes & Infections

    Article Title: Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

    doi: 10.1080/22221751.2021.1913973

    Figure Lengend Snippet: Correlation of SARS-CoV-2 neutralization titres (FRNT90) to A: SARS-CoV-2 whole-virion IgG ELISA; B: S1 IgG ELISA; C: RBD IgG ELISA and D: N IgG ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Article Snippet: S1- and nucleocapsid specific IgG antibodies were detected with commercially available SARS-CoV-2-IgG CE-IVD labelled ELISA kits from Euroimmun and Virotech respectively.

    Techniques: Neutralization, Enzyme-linked Immunosorbent Assay, Binding Assay

    Correlation of SARS-CoV-2 neutralization titres (FRNT90) of A: mild COVID-19 patients and B: severe COVID-19 patients to SARS-CoV-2 whole-virion IgG ELISA, S1 IgG ELISA, RBD IgG ELISA and N IgG ELISA Abbreviations: COVID-19: corona virus induced disease 19; FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Journal: Emerging Microbes & Infections

    Article Title: Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

    doi: 10.1080/22221751.2021.1913973

    Figure Lengend Snippet: Correlation of SARS-CoV-2 neutralization titres (FRNT90) of A: mild COVID-19 patients and B: severe COVID-19 patients to SARS-CoV-2 whole-virion IgG ELISA, S1 IgG ELISA, RBD IgG ELISA and N IgG ELISA Abbreviations: COVID-19: corona virus induced disease 19; FRNT90: Focus reduction neutralization titre 90; N: nucleocapsid protein; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; S1: subunit 1 of SARS-CoV-2 spike protein; * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.

    Article Snippet: S1- and nucleocapsid specific IgG antibodies were detected with commercially available SARS-CoV-2-IgG CE-IVD labelled ELISA kits from Euroimmun and Virotech respectively.

    Techniques: Neutralization, Enzyme-linked Immunosorbent Assay, Virus, Binding Assay

    Correlation of SARS-CoV-2 neutralization titres (FRNT90) to RBD IgGAM ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; **** = p < 0.0001.

    Journal: Emerging Microbes & Infections

    Article Title: Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort

    doi: 10.1080/22221751.2021.1913973

    Figure Lengend Snippet: Correlation of SARS-CoV-2 neutralization titres (FRNT90) to RBD IgGAM ELISA for samples ≤2 months PSO and 6–9 months PSO; Abbreviations: FRNT90: Focus reduction neutralization titre 90; PSO: post symptom onset; r: Spearman's rank correlation coefficient; RBD: receptor binding domain; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2; **** = p < 0.0001.

    Article Snippet: S1- and nucleocapsid specific IgG antibodies were detected with commercially available SARS-CoV-2-IgG CE-IVD labelled ELISA kits from Euroimmun and Virotech respectively.

    Techniques: Neutralization, Enzyme-linked Immunosorbent Assay, Binding Assay